• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类凝血激活的决定因素。

Determinants of coagulation activation in humans.

作者信息

Bauer K A, Eichinger S, Mannucci P M, Rosenberg R D

机构信息

Hematology-Oncology Section, Department of Medicine, Brockton-West Roxbury Department of Veterans Affairs Medical Center, Massachusetts 02132, USA.

出版信息

Haemostasis. 1996;26 Suppl 1:72-5. doi: 10.1159/000217244.

DOI:10.1159/000217244
PMID:8904177
Abstract

To evaluate the mechanism responsible for the generation of factor VIIa in vivo, we measured the levels of this enzyme after administering purified factor IX concentrates to patients with hemophilia B. Their factor VIIa levels were initially very low and gradually increased to normal, but there were no significant changes in the generation of factor Xa or thrombin. The administration of 10 mu g/kg body weight of recombinant factor VIIa to patients with factor VII deficiency increased the circulating levels 35-fold, but this only resulted in normalization of the activation of factor IX and factor X. Our data indicate that factor IXa is primarily responsible for the basal levels of free factor VIIa in vivo, and that changes in free factor VIIa in the blood do not necessarily lead to alterations in factor X activation.

摘要

为评估体内因子VIIa生成的机制,我们在给B型血友病患者输注纯化的因子IX浓缩物后测量了该酶的水平。他们的因子VIIa水平最初非常低,随后逐渐升至正常水平,但因子Xa或凝血酶的生成没有显著变化。给因子VII缺乏症患者静脉注射10μg/kg体重的重组因子VIIa后,循环水平升高了35倍,但这仅使因子IX和因子X的激活恢复正常。我们的数据表明,因子IXa是体内游离因子VIIa基础水平的主要原因,血液中游离因子VIIa的变化不一定会导致因子X激活的改变。

相似文献

1
Determinants of coagulation activation in humans.人类凝血激活的决定因素。
Haemostasis. 1996;26 Suppl 1:72-5. doi: 10.1159/000217244.
2
Determinants of plasma factor VIIa levels in humans.
Blood. 1995 Oct 15;86(8):3021-5.
3
Expression and characterization of a novel human recombinant factor IX molecule with enhanced in vitro and in vivo clotting activity.一种具有增强的体外和体内凝血活性的新型人重组凝血因子IX分子的表达与特性分析
Thromb Res. 2015 May;135(5):1017-24. doi: 10.1016/j.thromres.2015.02.034. Epub 2015 Mar 10.
4
Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex.在凝血因子IX第48位甘氨酸处发生突变的B型血友病患者,其凝血因子VIIa-组织因子复合物的激活出现延迟。
Thromb Haemost. 2000 Oct;84(4):626-34.
5
A candidate activation pathway for coagulation factor VII.凝血因子 VII 的候选激活途径。
Biochem J. 2019 Oct 15;476(19):2909-2926. doi: 10.1042/BCJ20190595.
6
Mechanism of factor VIIa-dependent coagulation in hemophilia blood.血友病血液中因子VIIa依赖性凝血的机制。
Blood. 2002 Feb 1;99(3):923-30. doi: 10.1182/blood.v99.3.923.
7
Extrinsic activation of human coagulation factors IX and X on the endothelial surface.人凝血因子IX和X在内皮表面的外源性激活。
Thromb Haemost. 1991 Sep 2;66(3):283-91.
8
Factor IX of the blood coagulation system: a review.血液凝固系统中的凝血因子IX:综述
Biochemistry (Mosc). 1997 Jul;62(7):685-93.
9
Measurement of basal levels of factor VIIa in hemophilia A and B patients.血友病A和B患者中凝血因子VIIa基础水平的测量。
Blood. 1992 Jul 1;80(1):25-8.
10
Recombinant factor VIIa does not induce hypercoagulability in vitro.
Thromb Haemost. 1999 Feb;81(2):245-9.